Inactive Instrument

News BBI Life Sciences Corporation

Equities

1035

KYG1089Y1180

Summary

Unlock all the news: Be the first to know and act before the market!

LJ Future Ltd completed the acquisition of 43.3% stake in BBI Life Sciences Corporation.	03/06/20	CI
BBI Life Sciences Corporation Appoints Liu Bin as a Non-Executive Director, Effective April 18, 2020	17/04/20	CI
BBI Life Sciences Corporation Did Not Recommend the Payment of A Final Dividend for the Year Ended December 31, 2019	31/03/20	CI
Bbi Life Sciences Corporation Reports Earnings Results for the Full Year Ended December 31, 2019	31/03/20	CI
LJ Future Ltd made a proposal to acquire 43.3% stake in BBI Life Sciences Corporation for approximately HKD 850 million.	19/01/20	CI
Bbi Life Sciences Corporation Reports Earnings Results for the Half Year Ended June 30, 2019	27/08/19	CI
BBI Life Sciences Corporation Recommends Final Dividend for the Year Ended December 31, 2018, Payable on 31 July 2019	27/03/19	CI
Bbi Life Sciences Corporation Reports Earnings Results for the Full Year Ended December 31, 2018	27/03/19	CI
BBI Life Sciences Corporation Announces Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2018	30/08/18	CI
BBI Life Sciences Corporation Provides Group Profit Guidance for the Six Months Ended June 30, 2018	14/08/18	CI
BBI Life Sciences Corporation Approves Final Dividend for the Year Ended 31 December 2017, Payable on or Around 31 July 2018	29/06/18	CI
BBI Life Sciences Corporation Announces Change of Principal Place of Business in Hong Kong	31/05/18	CI
BBI Life Sciences Corporation Announces Board Changes	20/04/18	CI
BBI Life Sciences Corporation Recommends Final Dividend for the Year Ended 31 December 2017, Payable on 31 July 2018	26/03/18	CI
BBI Life Sciences Corporation Announces Audited Consolidated Earnings Results for the Year Ended December 31, 2017	26/03/18	CI
BBI Life Sciences Corporation Announces Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2017	15/08/17	CI
Bbi Life Sciences : Monthly Return on Movements in Securities for the month ended 31/07/2017	03/08/17	PU
Bbi Life Sciences : Monthly Return on Movements in Securities for the month ended 30/06/2017	18/07/17	PU
BBI Life Sciences Corporation Proposes Final Dividend for the Year Ended December 31, 2016, Payable on June 30, 2017	24/04/17	CI
BBI Life Sciences Corporation Reports Audited Consolidated Capital Expenditure Results for the Year Ended December 31, 2016	24/04/17	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News BBI Life Sciences Corporation

Equities

1035

KYG1089Y1180

Summary

Filters